UBS Group’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.09M | Buy |
|
|||||
|
2025
Q2 | $603K | Sell |
|
|||||
|
2025
Q1 | $581K | Sell |
|
|||||
|
2024
Q4 | $729K | Buy |
|
|||||
|
2024
Q3 | $185K | Buy |
|
|||||
|
2024
Q2 | $126K | Sell |
|
|||||
|
2024
Q1 | $543K | Buy |
|
|||||
|
2023
Q4 | $6.98K | Buy |
|
|||||
|
2023
Q3 | $1.74K | Sell |
|
|||||
|
2023
Q2 | $5.23K | Buy |
|
|||||
|
2023
Q1 | $2.83K | Sell |
|
|||||
|
2022
Q4 | $456K | Buy |
|
|||||
|
2022
Q3 | $12K | Sell |
|
|||||
|
2022
Q2 | $352K | Buy |
|
|||||
|
2022
Q1 | $443K | Buy |
|
|||||
|
2021
Q4 | $594K | Buy |
|
|||||
|
2021
Q3 | $622K | Buy |
|
|||||
|
2021
Q2 | $112K | Sell |
|
|||||
|
2021
Q1 | $735K | Buy |
|
|||||
|
2020
Q4 | $949K | Buy |
|
|||||
|
2020
Q3 | $247K | Buy |
|